Platinum resistance related to a functional NER pathway.
Rosell
Rafael
R
Medical Oncology Service, Catalan Institute of Oncology, Badalona, Spain. rrosell@ico.scs.es
Mendez
Pedro
P
Isla
Dolores
D
Taron
Miquel
M
D002478:Cells, Cultured; D018736:DNA Adducts / Q000378:metabolism; D004260:DNA Repair / Q000187:drug effects* / Q000235:genetics; D004273:DNA, Neoplasm / Q000235:genetics / Q000378:metabolism; D004268:DNA-Binding Proteins / Q000378:metabolism; D019008:Drug Resistance, Neoplasm; D006801:Humans; D000071518:Liver X Receptors; D008175:Lung Neoplasms / Q000188:drug therapy* / Q000235:genetics / Q000503:physiopathology; D009711:Nucleotides / Q000235:genetics / Q000378:metabolism; D009944:Organoplatinum Compounds / Q000494:pharmacology*; D057093:Orphan Nuclear Receptors; D010597:Pharmacogenetics; D018160:Receptors, Cytoplasmic and Nuclear / Q000235:genetics / Q000378:metabolism*; D012680:Sensitivity and Specificity; D014026:Nicotiana / Q000009:adverse effects
D018736:DNA Adducts; D004273:DNA, Neoplasm; D004268:DNA-Binding Proteins; D000071518:Liver X Receptors; D009711:Nucleotides; D009944:Organoplatinum Compounds; D057093:Orphan Nuclear Receptors; D018160:Receptors, Cytoplasmic and Nuclear